PDCD1 and neoplasm: Recent evidence has pointed out that the PD‐1/PD‐L1 axis is typically altered in a significant proportion of OSCC cases, rendering this tumor type a promising candidate for immune checkpoint inhibitors, with the selective blockade of the PD‐L1/PD‐1 axis.